Ghost Tree Capital, LLC Sarepta Therapeutics, Inc. Transaction History

Ghost Tree Capital, LLC

  • $267 Million
  • Q3 2024

A detailed history of Ghost Tree Capital, LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Ghost Tree Capital, LLC holds 120,000 shares of SRPT stock, worth $14.3 Million. This represents 5.62% of its overall portfolio holdings.

Number of Shares
120,000
Previous 55,000 118.18%
Holding current value
$14.3 Million
Previous $8.69 Million 72.47%
% of portfolio
5.62%
Previous 3.55%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$124.33 - $156.75 $8.08 Million - $10.2 Million
65,000 Added 118.18%
120,000 $15 Million
Q2 2024

Aug 14, 2024
SELL
$113.33 - $163.85 $7.93 Million - $11.5 Million
-70,000 Reduced 56.0%
55,000 $8.69 Million
Q1 2024

May 15, 2024
BUY
$93.7 - $141.53 $2.34 Million - $3.54 Million
25,000 Added 25.0%
125,000 $16.2 Million
Q4 2023

Feb 14, 2024
BUY
$67.31 - $124.76 $4.04 Million - $7.49 Million
60,000 Added 150.0%
100,000 $9.64 Million
Q3 2023

Nov 14, 2023
SELL
$102.5 - $123.59 $4.61 Million - $5.56 Million
-45,000 Reduced 52.94%
40,000 $4.85 Million
Q2 2023

Aug 14, 2023
BUY
$106.4 - $157.19 $2.66 Million - $3.93 Million
25,000 Added 41.67%
85,000 $9.73 Million
Q1 2023

May 15, 2023
BUY
$117.53 - $155.99 $587,650 - $779,950
5,000 Added 9.09%
60,000 $8.27 Million
Q4 2022

Feb 14, 2023
SELL
$100.86 - $132.13 $5.55 Million - $7.27 Million
-55,000 Reduced 50.0%
55,000 $7.13 Million
Q3 2022

Nov 14, 2022
SELL
$75.71 - $119.24 $1.51 Million - $2.38 Million
-20,000 Reduced 15.38%
110,000 $12.2 Million
Q2 2022

Aug 15, 2022
BUY
$62.69 - $88.44 $5.02 Million - $7.08 Million
80,000 Added 160.0%
130,000 $9.75 Million
Q1 2022

May 16, 2022
SELL
$63.15 - $90.42 $3.16 Million - $4.52 Million
-50,000 Reduced 50.0%
50,000 $3.91 Million
Q4 2021

Feb 16, 2022
BUY
$77.28 - $99.42 $7.73 Million - $9.94 Million
100,000 New
100,000 $9.01 Million
Q1 2021

May 14, 2021
SELL
$72.25 - $168.95 $2.89 Million - $6.76 Million
-40,000 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
$125.56 - $178.74 $3.14 Million - $4.47 Million
-25,000 Reduced 38.46%
40,000 $6.82 Million
Q3 2020

Nov 16, 2020
BUY
$127.12 - $172.34 $8.26 Million - $11.2 Million
65,000 New
65,000 $9.13 Million
Q1 2020

May 15, 2020
SELL
$82.38 - $131.64 $5.35 Million - $8.56 Million
-65,000 Closed
0 $0
Q4 2019

Feb 14, 2020
SELL
$76.53 - $135.58 $11.9 Million - $21 Million
-155,000 Reduced 70.45%
65,000 $8.39 Million
Q3 2019

Nov 14, 2019
SELL
$72.81 - $156.91 $5.1 Million - $11 Million
-70,000 Reduced 24.14%
220,000 $16.6 Million
Q2 2019

Aug 14, 2019
BUY
$112.21 - $151.95 $32.5 Million - $44.1 Million
290,000 New
290,000 $44.1 Million
Q1 2019

May 15, 2019
SELL
$106.67 - $151.68 $7.47 Million - $10.6 Million
-70,000 Closed
0 $0
Q4 2018

Feb 14, 2019
SELL
$97.32 - $148.76 $13.6 Million - $20.8 Million
-140,000 Reduced 66.67%
70,000 $7.64 Million
Q3 2018

Nov 14, 2018
BUY
$115.31 - $161.51 $4.04 Million - $5.65 Million
35,000 Added 20.0%
210,000 $33.9 Million
Q2 2018

Aug 14, 2018
SELL
$71.74 - $153.69 $4.3 Million - $9.22 Million
-60,000 Reduced 25.53%
175,000 $23.1 Million
Q1 2018

May 15, 2018
BUY
$54.02 - $82.27 $12.7 Million - $19.3 Million
235,000 New
235,000 $17.4 Million
Q4 2017

Feb 14, 2018
SELL
$47.64 - $56.75 $4.76 Million - $5.68 Million
-100,000 Closed
0 $0
Q3 2017

Nov 14, 2017
BUY
$35.73 - $47.15 $3.57 Million - $4.72 Million
100,000
100,000 $4.54 Million

Others Institutions Holding SRPT

# of Institutions
529
Shares Held
84.2M
Call Options Held
2.06M
Put Options Held
1.52M
View Full List

About Sarepta Therapeutics, Inc.

SRPT Quotes by TradingView
  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $10.4B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Ghost Tree Capital, LLC Portfolio

Follow Ghost Tree Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ghost Tree Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email